SCHEMBL6789042

SCHEMBL6789042

[C]1CN(c2cc3ccccc3[nH]2)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HRH4 Q9H3N8 4/20 0.35
HRH3 Q9Y5N1 2/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.33
FLT3 P36888 1/20 0.33
CYP2A6 P11509 1/20 0.33
DAO P14920 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
SRD5A2 P31213 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BRD4 O60885 1/20 0.33
DDO Q99489 1/20 0.33
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL930442 0.71 TSHR (0.55) AOC3ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL29713612 0.71 TSHR (0.55) AOC3ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL27889736 0.69 AOC3 (0.46) AOC3HRH4HRH3NPC1RAB9A
SCHEMBL7715904 0.69 TSHR (0.46) AOC3ALDH1A1HRH3SMN1; SMN2KDM4E
SCHEMBL7407639 0.67 ITK (0.38) AOC3HRH3NPC1RAB9AKDR
SCHEMBL2450522 0.67 HRH4 (0.37) AOC3ALDH1A1HRH4HRH3NPC1
SCHEMBL29866067 0.66 AOC3 (0.42) AOC3HRH4HRH3NPC1RAB9A
SCHEMBL11667140 0.66 AOC3 (0.42) AOC3HRH4HRH3NPC1RAB9A
SCHEMBL8087823 0.65 HRH3 (0.50) AOC3ALDH1A1HRH4HRH3NPC1
SCHEMBL9462932 0.65 AOC3 (0.41) AOC3ALDH1A1HRH4HRH3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040077684-A1 Piperidinyl compounds that selectively bind integrins JANSSEN PHARMACEUTICA, NV (BE) 2004-04-22 US disclosed
WO-2004020435-A1 PIPERIDINYL COMPOUNDS THAT SELECTIVELY BIND INTEGRINS JANSSEN PHARMACEUTICA N.V. (BE) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077684-A1 Piperidinyl compounds that selectively bind integrins ITGB3, ITGAV, ITGA2B AOC3 4534/4885ALDH1A1 1751/4885HRH4 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.